Last reviewed · How we verify
NCT03614377: DEDiCATES
DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)
trial testing Device interrogation in Sleep Disorder in 600 participants. Status unknown.
31 July 2022
Quick facts
| Lead sponsor | Samsung Medical Center |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 28 April 2017 |
| Primary completion | 31 July 2022 |
| Estimated completion | 31 July 2022 |
| Sites | 15 locations across South Korea |
Drugs / interventions tested
- Device interrogation
Conditions studied
- Sleep Disorder — all drugs for Sleep Disorder →
- Cardiac Arrythmias — all drugs for Cardiac Arrythmias →
- Cardiac Event — all drugs for Cardiac Event →
- Cardiac Implantable Electronic Device — all drugs for Cardiac Implantable Electronic Device →
Sponsor
Samsung Medical Center
Who can join
19 and older, any sex, with Sleep Disorder or Cardiac Arrythmias. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective multicenter registry study aims to determine whether device-detected sleep-disordered breathing events are associated increased risk of cardiac arrhythmias or other cardiovascular outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03614377
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Device interrogation
Trials testing the same drug.
- NCT04397224 — Reduction or Extension of COnduction Time With Ventricular Electromechanical Remodeling (RECOVER) · unknown
Other recruiting trials for Sleep Disorder
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT06990256 — Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers · NA · recruiting
- NCT04949360 — SleepUp Digital CBTi-based Platform for Insomnia · NA · recruiting
- NCT05649514 — Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease · NA · recruiting
- NCT06914466 — Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD · recruiting
Other Samsung Medical Center trials
Trials by the same sponsor.
- NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
- NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
- NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
- NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
- NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03614377 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
- Last refreshed: 30 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03614377.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing